Recent news on Nabilone

Teen's diary shows others how to tackle cancer  -  Mar 5, 2007
Telegraph.co.uk,In another extract about the anti-sickness drug nabilone, she wrote: "It's a cannabis derivative drug but no, you don't get high.

Valeant: eyes indication expansion of Cesamet  -  Feb 23, 2007
Pharmaceutical Business ReviewValeant Pharmaceuticals has filed an application with the FDA to test Cesamet (nabilone) oral capsules as a treatment of cancer chemotherapy-induced

Valeant Pharmaceuticals Acquires Rights to Nabilone in United ...  -  Feb 16, 2007
PharmaLive.com (press release),Valeant markets nabilone in the United States and Canada under the brand name Cesamet(R). Nabilone is indicated for use in the treatment of nausea and

Valeant Pharmaceuticals Acquires Rights to Nabilone in United ...  -  Feb 15, 2007
Genetic Engineering News (press release),Valeant Pharmaceuticals International (NYSE:VRX) today announced that it has acquired the commercial rights to nabilone in the United Kingdom and other

Market Report -- In Play (VRX)  -  Feb 15, 2007
MSN MoneyValeant Pharmaceuticals acquires rights to Nabilone in United Kingdom and Europe Co announces it has acquired the commercial rights to nabilone in the

Valeant Pharmaceuticals Files Investigational New Drug Application ...  -  Feb 23, 2007
PharmaLive.com (press release),...sedatives, hypnotics, or other psychoactive substances because these substances can potentiate the central nervous system effects of nabilone.

Valeant Pharmaceuticals (VRX) Files IND with FDA for Cesamet  -  Feb 22, 2007
StreetInsider.com (subscription),US Food and Drug Administration (FDA) for Cesamet(R) (CII) (nabilone) oral capsules for the treatment of cancer chemotherapy-induced neuropathic pain.

Biotech Stock Review: GPC Biotech Completes New Drug Approval  -  Feb 20, 2007
Seeking Alpha,Valeant (VRX) acquired the rights to anti-nausea drug nabilone for the UK and Europe. Valeant already owns rights to the drug for Canada and the US,

NCCN Updates Antiemesis Guidelines  -  Jan 8, 2007
PharmaLive.com (press release),Nabilone (Cesamet, Valeant) is now recommended for breakthrough treatment. The guidelines table describing the emetogenic potential of different

Nabilone Could Treat Chorea and Irritability in Huntington’s Disease  -  Nov 29, 2006
Journal of Neuropsychiatry (subscription)9 In one single patient, single dose, uncontrolled open clinical trial using nabilone, 1.5mg, the chorea increased significantly.

Synthetic marijuana helps cancer patients - study  -  Dec 16, 2006
Reuters South Africa,The 139-patient study involved a drug called nabilone, sold under the brand name Cesamet by Valeant Pharmaceuticals International.

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional